Evidence map›Paper›PMID 31625862›Full record

ArticleEmerging infectious diseases2019

Routine Culture-Resistant Mycobacterium tuberculosis Rescue and Shell-Vial Assay, France.

Mustapha Fellag, Jamal Saad, Nicholas Armstrong, Eric Chabrière, Carole Eldin, Jean-Christophe Lagier, Michel Drancourt

Open access · diamondAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mustapha Fellag
Jamal Saad
Nicholas Armstrong
Eric Chabrière
Carole Eldin
Jean-Christophe Lagier
Michel Drancourt
Méditerranée Infection Foundation · FRAix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We used shell-vial assay with a medium that buffered rifampin to isolate routine culture-resistant Mycobacterium tuberculosis bacteria from cerebrospinal fluid and rifampin-containing intervertebral disc and vertebral corpus of a patient in treatment for Pott's disease and disseminated tuberculosis. Whole-genome sequencing confirmed M. tuberculosis lineage 4 (Euro-American) strain.

Indexed as

Antitubercular AgentsBiopsyFranceGenome, BacterialHumansMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular Agentsantimicrobial resistancebacteriacultureFranceMycobacterium tuberculosisshell-vial assaytuberculosistuberculosis and other mycobacteria

Identifiers

PMID31625862
PMCPMC6810202
OpenAlexW2978104046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.